Unveiling SIDS: New Study Links Infant Liver Enzymes to Vaccine Safety Concerns

A groundbreaking systematic review has shed new light on the potential link between sudden infant death syndrome (SIDS) and vaccine safety, focusing on the role of cytochrome P450 (CYP450) enzymes in infants.

These enzymes, critical for detoxifying drugs, toxins, and vaccine excipients like aluminum and polysorbate 80, are found to be developmentally immature in young infants. The review also highlights genetic polymorphisms that may exacerbate this vulnerability, potentially impairing the clearance of vaccine components.

The study reveals a temporal clustering of some SIDS cases following vaccination, though causality remains unproven. Inflammation, which can suppress CYP450 enzyme function, may contribute to metabolic vulnerabilities in infants, potentially triggering severe outcomes such as cytokine storms.

These inflammatory responses could disrupt critical pathways, including the serotonin-mediated autonomic nervous system, which regulates breathing. Such disruptions may explain the sudden cessation of breathing observed in SIDS cases.

Current postmortem protocols often fail to investigate these metabolic and inflammatory pathways, leaving critical questions unanswered. This research marks a significant step toward understanding SIDS and could reshape the scientific and medical discourse surrounding infant mortality.

If validated, these findings may bring justice to grieving parents who have been told SIDS is simply an unexplained phenomenon. Further studies are urgently needed to explore this pathway and ensure infant safety.

@DelBigtree